Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neridronate versus placebo for algodystrophic syndrome
2007-003372-18Phase 3Completed
- Sponsor
- Abiogen Pharma
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) and complex regional pain syndrome (CRPS) comparing Neridronate with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jan 2008; status: completed.
02
Drugs
neridronic acid
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on 2007-003372-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003372-18.